Please Wait.....
Report
Drug-Eluting Stents Market (Material: Metal and Polymer; Drug: Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others; Application: Coronary Artery Disease, Peripheral Artery Disease and Others; and End-user: Hospitals, Ambulatory Surgical Centers and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
Market Report I 2025-04-11 I 205 Pages I Transparency Market Research
Drug-Eluting Stents Market - Scope of Report
TMR's report on the global drug-eluting stents market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global drug-eluting stents market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug-eluting stents market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug-eluting stents market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug-eluting stents market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug-eluting stents market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug-eluting stents market.
The report delves into the competitive landscape of the global drug-eluting stents market. Key players operating in the global drug-eluting stents market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug-eluting stents market profiled in this report.
Key Questions Answered in global drug-eluting stents Market Report
- What is the sales/revenue generated by drug-eluting stents across all regions during the forecast period?
- What are the opportunities in the global drug-eluting stents market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2035?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Drug-Eluting Stents Market - Research Objectives and Research Approach
The comprehensive report on the global drug-eluting stents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global drug-eluting stents market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug-eluting stents market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-Eluting Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug-Eluting Stents Market Analysis and Forecast, 2020-2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. PORTER's Five Forces Analysis
5.3. PESTEL Analysis
5.4. Supply Chain Analysis
5.5. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.6. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.7. Regulatory Scenario by Key Country/Region
5.8. Research and Development Trends
5.9. Go-to-Market Strategy for New Market Entrants
6. Global Drug-Eluting Stents Market Analysis and Forecast, by Material
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Material, 2020-2035
6.3.1. Metal
6.3.1.1. Stainless-Steel
6.3.1.2. Cobalt-Chromium
6.3.1.3. Nitinol
6.3.1.4. Others
6.3.2. Polymer
6.3.2.1. Non-biodegradable Polymers
6.3.2.2. Biodegradable Polymers
6.4. Market Attractiveness Analysis, by Material
7. Global Drug-Eluting Stents Market Analysis and Forecast, by Drug
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Drug, 2020-2035
7.3.1. Sirolimus
7.3.2. Paclitaxel
7.3.3. Zotarolimus
7.3.4. Everolimus
7.3.5. Others
7.4. Market Attractiveness Analysis, by Drug
8. Global Drug-Eluting Stents Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application , 2020-2035
8.3.1. Coronary Artery Disease
8.3.2. Peripheral Artery Disease
8.3.3. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Drug-Eluting Stents Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2035
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Drug-Eluting Stents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2035
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Region
11. North America Drug-Eluting Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2020-2035
11.2.1. Metal
11.2.1.1. Stainless-Steel
11.2.1.2. Cobalt-Chromium
11.2.1.3. Nitinol
11.2.1.4. Others
11.2.2. Polymer
11.2.2.1. Non-biodegradable Polymers
11.2.2.2. Biodegradable Polymers
11.3. Market Value Forecast, by Drug, 2020-2035
11.3.1. Sirolimus
11.3.2. Paclitaxel
11.3.3. Zotarolimus
11.3.4. Everolimus
11.3.5. Others
11.4. Market Value Forecast, by Application , 2020-2035
11.4.1. Coronary Artery Disease
11.4.2. Peripheral Artery Disease
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2020-2035
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country, 2020-2035
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Material
11.7.2. By Drug
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Drug-Eluting Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2020-2035
12.2.1. Metal
12.2.1.1. Stainless-Steel
12.2.1.2. Cobalt-Chromium
12.2.1.3. Nitinol
12.2.1.4. Others
12.2.2. Polymer
12.2.2.1. Non-biodegradable Polymers
12.2.2.2. Biodegradable Polymers
12.3. Market Value Forecast, by Drug, 2020-2035
12.3.1. Sirolimus
12.3.2. Paclitaxel
12.3.3. Zotarolimus
12.3.4. Everolimus
12.3.5. Others
12.4. Market Value Forecast, by Application , 2020-2035
12.4.1. Coronary Artery Disease
12.4.2. Peripheral Artery Disease
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2020-2035
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
12.6.1. Germany
12.6.2. UK
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Material
12.7.2. By Drug
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Drug-Eluting Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Material, 2020-2035
13.2.1. Metal
13.2.1.1. Stainless-Steel
13.2.1.2. Cobalt-Chromium
13.2.1.3. Nitinol
13.2.1.4. Others
13.2.2. Polymer
13.2.2.1. Non-biodegradable Polymers
13.2.2.2. Biodegradable Polymers
13.3. Market Value Forecast, by Drug, 2020-2035
13.3.1. Sirolimus
13.3.2. Paclitaxel
13.3.3. Zotarolimus
13.3.4. Everolimus
13.3.5. Others
13.4. Market Value Forecast, by Application , 2020-2035
13.4.1. Coronary Artery Disease
13.4.2. Peripheral Artery Disease
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2020-2035
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Material
13.7.2. By Drug
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Drug-Eluting Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Material, 2020-2035
14.2.1. Metal
14.2.1.1. Stainless-Steel
14.2.1.2. Cobalt-Chromium
14.2.1.3. Nitinol
14.2.1.4. Others
14.2.2. Polymer
14.2.2.1. Non-biodegradable Polymers
14.2.2.2. Biodegradable Polymers
14.3. Market Value Forecast, by Drug, 2020-2035
14.3.1. Sirolimus
14.3.2. Paclitaxel
14.3.3. Zotarolimus
14.3.4. Everolimus
14.3.5. Others
14.4. Market Value Forecast, by Application , 2020-2035
14.4.1. Coronary Artery Disease
14.4.2. Peripheral Artery Disease
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2020-2035
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Material
14.7.2. By Drug
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Drug-Eluting Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Material, 2020-2035
15.2.1. Metal
15.2.1.1. Stainless-Steel
15.2.1.2. Cobalt-Chromium
15.2.1.3. Nitinol
15.2.1.4. Others
15.2.2. Polymer
15.2.2.1. Non-biodegradable Polymers
15.2.2.2. Biodegradable Polymers
15.3. Market Value Forecast, by Drug, 2020-2035
15.3.1. Sirolimus
15.3.2. Paclitaxel
15.3.3. Zotarolimus
15.3.4. Everolimus
15.3.5. Others
15.4. Market Value Forecast, by Application , 2020-2035
15.4.1. Coronary Artery Disease
15.4.2. Peripheral Artery Disease
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2020-2035
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Material
15.7.2. By Drug
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2024)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategies
16.3.1.5. Recent Developments
16.3.2. AlviMedica
16.3.2.1. Company Overview
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Business Strategies
16.3.2.5. Recent Developments
16.3.3. B. Braun Melsungen AG
16.3.3.1. Company Overview
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Business Strategies
16.3.3.5. Recent Developments
16.3.4. Biosensors International Group, Ltd.
16.3.4.1. Company Overview
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Business Strategies
16.3.4.5. Recent Developments
16.3.5. Shandong JW Medical Systems LTD.
16.3.5.1. Company Overview
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Business Strategies
16.3.5.5. Recent Developments
16.3.6. Boston Scientific Corporation
16.3.6.1. Company Overview
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Business Strategies
16.3.6.5. Recent Developments
16.3.7. Cook Medical Inc.
16.3.7.1. Company Overview
16.3.7.2. Financial Overview
16.3.7.3. Product Portfolio
16.3.7.4. Business Strategies
16.3.7.5. Recent Developments
16.3.8. Elixir Medical Corp.
16.3.8.1. Company Overview
16.3.8.2. Financial Overview
16.3.8.3. Product Portfolio
16.3.8.4. Business Strategies
16.3.8.5. Recent Developments
16.3.9. Lepu Medical Technology (Beijing) Co., Ltd.
16.3.9.1. Company Overview
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Business Strategies
16.3.9.5. Recent Developments
16.3.10. Medtronic plc
16.3.10.1. Company Overview
16.3.10.2. Financial Overview
16.3.10.3. Product Portfolio
16.3.10.4. Business Strategies
16.3.10.5. Recent Developments
16.3.11. Eurocor GmbH
16.3.11.1. Company Overview
16.3.11.2. Financial Overview
16.3.11.3. Product Portfolio
16.3.11.4. Business Strategies
16.3.11.5. Recent Developments
16.3.12. OrbusNeich Medical Company Limited
16.3.12.1. Company Overview
16.3.12.2. Financial Overview
16.3.12.3. Product Portfolio
16.3.12.4. Business Strategies
16.3.12.5. Recent Developments
16.3.13. Shanghai MicroPort Medical Co., Ltd.
16.3.13.1. Company Overview
16.3.13.2. Financial Overview
16.3.13.3. Product Portfolio
16.3.13.4. Business Strategies
16.3.13.5. Recent Developments
16.3.14. Sino Medical Sciences Technology Inc.
16.3.14.1. Company Overview
16.3.14.2. Financial Overview
16.3.14.3. Product Portfolio
16.3.14.4. Business Strategies
16.3.14.5. Recent Developments
List of Tables
Table 01: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 02: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 03: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 04: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 05: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 06: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 07: Global Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Region, 2020-2035
Table 08: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 09: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 10: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 11: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 12: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 13: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 14: North America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 15: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 16: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 17: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 18: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 19: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 20: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 21: Europe - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 22: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 23: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 24: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 25: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 26: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 27: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 28: Asia Pacific - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 29: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 30: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 31: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 32: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 33: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 34: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 35: Latin America - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
Table 36: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
Table 37: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Material, 2020-2035
Table 38: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Metal, 2020-2035
Table 39: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Polymer, 2020-2035
Table 40: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Drug, 2020-2035
Table 41: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By Application, 2020-2035
Table 42: Middle East & Africa - Drug-Eluting Stents Market Value (US$ Bn) Forecast, By End-user, 2020-2035
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security